Fate Therapeutics
FATE
#7514
Rank
โ‚ฌ0.25 B
Marketcap
2,24ย โ‚ฌ
Share price
-5.10%
Change (1 day)
12.27%
Change (1 year)

Revenue for Fate Therapeutics (FATE)

Revenue in 2024 (TTM): โ‚ฌ11.45 Million

According to Fate Therapeutics 's latest financial reports the company's current revenue (TTM ) is โ‚ฌ11.4 Million. In 2023 the company made a revenue of โ‚ฌ57.47 Million a decrease over the revenue in the year 2022 that were of โ‚ฌ89.77 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Fate Therapeutics from 2013 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚ฌ11.45 M-80.07%
2023 โ‚ฌ57.47 M-35.98%
2022 โ‚ฌ89.77 M82.05%
2021 โ‚ฌ49.31 M92.96%
2020 โ‚ฌ25.55 M168.06%
2019 โ‚ฌ9.53 M130.1%
2018 โ‚ฌ4.14 M21.08%
2017 โ‚ฌ3.42 M-18.23%
2016 โ‚ฌ4.18 M88.23%
2015 โ‚ฌ2.22 M
2014 N/A-100%
2013 โ‚ฌ0.7 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚ฌ1.39 B 12,118.83%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ18.36 B 160,880.76%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.83 B 7,210.66%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ9.81 M-13.95%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ2.07 B 18,108.98%๐Ÿ‡บ๐Ÿ‡ธ USA